Skip to main content
CHEMCLIN DIAGNOSTICS CO., LTD. logo

CHEMCLIN DIAGNOSTICS CO., LTD. — Investor Relations & Filings

Ticker · 688468 ISIN · CNE100005311 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2022-12-21 Director's Dealing
Country CN China
Listing Shanghai Stock Exchange 688468

About CHEMCLIN DIAGNOSTICS CO., LTD.

https://www.chemclin.com/

CHEMCLIN DIAGNOSTICS CO., LTD. specializes in the research, development, and manufacturing of in vitro diagnostic systems and reagents. The company is primarily recognized for its proprietary Light-initiated Chemiluminescent Assay (LiCA) technology, a homogeneous chemiluminescence platform that eliminates the need for washing steps, thereby enhancing testing efficiency and precision. Its product portfolio includes fully automated immunoassay analyzers and a comprehensive range of diagnostic kits covering infectious diseases, cardiac markers, thyroid function, tumor markers, and reproductive health. By integrating advanced biotechnology with automated instrumentation, the company provides clinical laboratories and medical institutions with high-sensitivity diagnostic solutions designed to improve patient care and laboratory workflow.

Recent filings

Filing Released Lang Actions
科美诊断技术股份有限公司关于股东违规减持公司股票并致歉的公告
Director's Dealing Classification · 95% confidence The document is a public announcement by the company regarding a violation of shareholding reduction rules by a major shareholder and its related parties. It details the shareholding situation before the violation, the nature of the violation (exceeding the allowed reduction limit within a 90-day period), and the apology and corrective measures taken. The document does not contain financial statements, earnings data, or detailed management analysis. It is a regulatory disclosure about insider share transactions and compliance with stock exchange rules. This fits the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives or major shareholders' shareholding changes and related compliance issues. The document length is 1635 characters, which is short and focused on a specific shareholding event, not a full report or announcement of a report publication. Therefore, the best classification is DIRS with high confidence.
2022-12-21 Chinese
科美诊断技术股份有限公司关于全资子公司诉讼结果的公告
Legal Proceedings Report Classification · 100% confidence The document is a legal announcement regarding the final judgment of a lawsuit involving the company and its subsidiary. It details the litigation stage, parties involved, amounts in dispute, and the court's decision. It explicitly states the impact on the company's profits and references previous disclosures. There are no financial statements or detailed financial data presented, nor is this a report or presentation. The document is an update on legal proceedings and court rulings, fitting the category of Legal Proceedings Report.
2022-12-18 Chinese
科美诊断技术股份有限公司关于持股5%以上股东权益变动达到1%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a formal announcement regarding a change in shareholding by a significant shareholder (over 5%) of the company 科美诊断技术股份有限公司. It details the reduction in shares held by 横琴君联致康 and its related party LOYAL CLASS, including specific share counts, percentages, and dates of transactions. The document explicitly states that this is a notification of a shareholding change and does not involve a takeover or control change. There is no financial statement, earnings data, or management discussion present. The content fits the definition of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds.
2022-12-16 Chinese
科美诊断技术股份有限公司关于持股5%以上股东减持计划数量过半的进展公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from a company regarding the progress of a shareholding reduction plan by shareholders holding more than 5% of the company's shares. It details the shareholders involved, the number of shares reduced, the percentage of total shares, and the impact on company control. The document is regulatory in nature, providing updates on shareholding changes but does not contain financial statements, earnings data, or detailed financial analysis. It is not a full report but an announcement about shareholding changes. Therefore, it fits best under the category of Major Shareholding Notification (MRQ). The document length is short and focused on shareholding changes, confirming this classification with high confidence.
2022-12-15 Chinese
科美诊断技术股份有限公司关于自愿披露公司获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a medical device registration certificate from the National Medical Products Administration. It details the product registration information, expected impact on the company, and a risk warning. The document is short (752 characters) and does not contain financial data, financial results, or detailed management discussion. It is an official regulatory announcement about product registration and its potential impact, not a financial report or management change. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-12-09 Chinese
科美诊断技术股份有限公司关于持股5%以上股东权益变动达到1%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a detailed announcement about a shareholder's equity change, specifically a reduction in shareholding by Shenzhen Ping An Real Estate Investment Co., Ltd. and its concerted parties. It includes specifics on share quantities before and after the change, dates of transactions, and regulatory compliance statements. The document explicitly states it is an announcement of a shareholder's equity change exceeding 1%, which is a classic example of a Major Shareholding Notification. It is not a financial report, earnings release, or management report, nor is it a proxy or voting result announcement. The document length is 2635 characters, which is typical for such announcements. Therefore, the correct classification is Major Shareholding Notification (MRQ).
2022-12-02 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.